Avro

About:

Avro Life Science is developing skin patches for generic drug delivery, focusing on therapeutics for children and the elderly.

Website: https://www.avrolifesci.com/

Twitter/X: AvroSci

Top Investors: Y Combinator, Creative Destruction Lab (CDL), UpHonest Capital, Fifty Years, Garage Capital

Description:

Avro Life Science is developing skin patches for generic drug delivery, focusing on therapeutics for children and the elderly. The core of our technology is a novel biopolymer which is used as a platform for passive transdermal drug delivery of small molecules and drugs.

Total Funding Amount:

$2.24M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Waterloo, Ontario, Canada

Founded Date:

2016-01-01

Contact Email:

contact(AT)avrolifescience.com

Founders:

Keean Sarani, Shakir Lakhani

Number of Employees:

1-10

Last Funding Date:

2021-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai